Clinical Trial Update: Trial of C134 in Patients With Recurrent GBM [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for C134 in recurrent glioblastoma and related brain cancers reports results with results posted on 2025-07-03. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• C134

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-03